Goodwin Procter LLP advised Doximity on the deal. Doximity (NYSE: DOCS) announced its initial public offering of 23,300,000 shares of its Class A common stock at a...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Zai Lab Limited on the deal. Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) announced its broad strategic collaboration and license agreement with MacroGenics...
You must be a Standard 1 Year member to access this content.
Sidley Austin advised Sixth Street and Goldman Sachs on the deal while Goodwin Procter LLP represented Datavant. Ropes & Gray represented New Mountain Capital and its...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Cathay Health, Polaris Partners, and Newpath Partners on the deal. Cathay Health, Polaris Partners, and Newpath Partners lead the Kojin Therapeutics’ $60 Million Series...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Akili Interactive on the deal. Akili Interactive announced its $160 million in combined equity and debt financing. Akili is the maker of EndeavorRx™,...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised the underwriters on the deal. Privia Health Group, Inc. (“Privia Health”) (Nasdaq: PRVA), a technology-driven, national physician enablement company that collaborates with...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Chiasma, Inc. on the deal. Chiasma, Inc. (Nasdaq: CHMA) announced its definitive agreement to be acquired by Amryt Pharma plc (Nasdaq: AMYT, AIM:...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Markforged on the deal, while Cadwalader advised One.Markforged announced its definitive agreement to merge with One (NYSE: AONE), a special purpose acquisition company...
You must be a Standard 1 Year member to access this content.
